UNSPSC 51352311: Estrazinol hydrobromide

This classification denotes a selective estrogen receptor modulator with the molecular formula C20H25NO2.BRH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P1NC244SOF. The term estrazinol hydrobromide is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule estrazinol hydrobromide under HS 29372300 and SITC 54153. As of Q4 2014, ESTRAZINOL HYDROBROMIDE remains US FDA's Preferred Term for this commodity.

Estrazinol hydrobromide bears US NLM identifiers UMLS ID C2700020 and NCI Concept Code C74403. SMILES: C[C@]12CC[C@@H]3C4CCC(CC4CCN3[C@@H]1CC[C@]2(C#C)O)OC.BR.

UNSPSC 51352311 Estrazinol hydrobromide is a Commodity code for a specific pharmaceutical ingredient with minimal recent state and local procurement activity. State and local governments do not typically purchase this chemical compound directly; it appears in the UNSPSC taxonomy primarily to support pharmaceutical manufacturers and research institutions that may source it through state procurement channels, but no recent state or local solicitations have tagged activity under this code.

The absence of recent opportunities under this code reflects the narrow and specialized nature of the commodity. Estrazinol hydrobromide is a niche pharmaceutical intermediate that would be procured by state universities, research departments, or health-system laboratories rather than by general-purpose government agencies. Without concrete recent solicitations to reference, buyers should monitor this code only if operating within pharmaceutical manufacturing, chemical research, or specialized laboratory supply chains serving public institutions.